Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 2/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | IDO1 | P14902 | 2/20 | 0.34 |
| ▸ | SLC18A3 | Q16572 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.34 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.34 |
| ▸ | HSP90AA1 | P07900 | 2/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.32 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13456274 | 1.00 | CYP3A4 (0.38) | CYP3A4TDP1GAAPOLBIDO1 | |
| SCHEMBL301035 | 1.00 | CYP3A4 (0.38) | CYP3A4TDP1GAAPOLBIDO1 | |
| SCHEMBL34871 | 1.00 | CYP3A4 (0.38) | CYP3A4TDP1GAAPOLBIDO1 | |
| SCHEMBL9202452 | 0.98 | CYP3A4 (0.36) | CYP3A4TDP1GAAPOLBIDO1 | |
| Hydrochloric Acid SCHEMBL1582526 | 0.98 | IDO1 (0.36) | CYP3A4TDP1GAAPOLBIDO1 | |
| SCHEMBL32681735 | 0.98 | CYP3A4 (0.36) | CYP3A4TDP1GAAPOLBIDO1 | |
| SCHEMBL9634685 | 0.98 | CYP3A4 (0.36) | CYP3A4TDP1GAAPOLBIDO1 | |
| Hydrochloric Acid SCHEMBL1582528 | 0.98 | IDO1 (0.36) | CYP3A4TDP1GAAPOLBIDO1 | |
| Hydrochloric Acid SCHEMBL28452606 | 0.98 | IDO1 (0.36) | CYP3A4TDP1GAAPOLBIDO1 | |
| Phosphine SCHEMBL28863563 | 0.98 | CYP3A4 (0.36) | CYP3A4TDP1GAAPOLBIDO1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12018152-B2 | Polybutadiene composition and method for producing same | ENEOS MATERIALS CORPORATION (JP) | 2024-06-25 | — | — | US | disclosed |
| EP-3896100-B1 | POLYBUTADIENE COMPOSITION AND METHOD FOR PRODUCING SAME | ENEOS MAT CORPORATION (JP) | 2023-06-21 | — | — | EP | disclosed |
| US-20220002524-A1 | POLYBUTADIENE COMPOSITION AND METHOD FOR PRODUCING SAME | JSR CORPORATION (JP) | 2022-01-06 | — | — | US | disclosed |
| EP-3896100-A1 | POLYBUTADIENE COMPOSITION AND METHOD FOR PRODUCING SAME | JSR Corporation (JP) | 2021-10-20 | — | — | EP | disclosed |
| CN-113056494-A | Polybutadiene composition and method for producing same | JSR株式会社 | 2021-06-29 | — | — | CN | disclosed |
| WO-2020122108-A1 | POLYBUTADIENE COMPOSITION AND METHOD FOR PRODUCING SAME | JSR株式会社 | 2020-06-18 | — | — | WO | disclosed |
| EP-2610248-B1 | METHOD FOR PRODUCING PHENYL-SUBSTITUTED HETEROCYCLIC DERIVATIVE BY MEANS OF COUPLING METHOD USING A PALLADIUM COMPOUND | TEIJIN PHARMA LTD (JP) | 2016-06-08 | — | — | EP | disclosed |
| US-8952174-B2 | Process for producing phenyl-substituted heterocyclic derivative through coupling using transition metal catalyst | TEIJIN PHARMA LIMITED (JP) | 2015-02-10 | — | — | US | disclosed |
| US-8916714-B2 | Method for producing phenyl-substituted heterocyclic derivative by means of coupling method using palladium compound | TEIJIN PHARMA LIMITED (JP) | 2014-12-23 | — | — | US | disclosed |
| EP-2610248-A1 | METHOD FOR PRODUCING PHENYL-SUBSTITUTED HETEROCYCLIC DERIVATIVE BY MEANS OF COUPLING METHOD USING A PALLADIUM COMPOUND | Teijin Pharma Limited (JP) | 2013-07-03 | — | — | EP | disclosed |
| EP-2404908-A1 | PROCESS FOR PRODUCING PHENYL-SUBSTITUTED HETEROCYCLIC DERIVATIVE THROUGH COUPLING USING TRANSITION METAL CATALYST | Teijin Pharma Limited (JP) | 2012-01-11 | — | — | EP | disclosed |
| US-20110313169-A1 | PROCESS FOR PRODUCING PHENYL-SUBSTITUTED HETEROCYCLIC DERIVATIVE THROUGH COUPLING USING TRANSITION METAL CATALYST | TEIJIN PHARMA LIMITED (JP) | 2011-12-22 | — | — | US | disclosed |
| EP-1535931-B1 | PROCESS FOR PRODUCING CRYSTALLINE 1,2-POLYBUTADIENE | JSR CORP (JP) | 2011-04-20 | — | — | EP | disclosed |
| US-7009013-B2 | Process for producing crystalline 1,2-polybutadiene | JSR CORPORATION (JP) | 2006-03-07 | — | — | US | disclosed |
| US-20050239982-A1 | Process for producing crystalline 1,2-polybutadiene | JSR CORPORATION (JP) | 2005-10-27 | — | — | US | disclosed |
| EP-1535931-A1 | PROCESS FOR PRODUCING CRYSTALLINE 1,2-POLYBUTADIENE | JSR Corporation (JP) | 2005-06-01 | — | — | EP | disclosed |
| EP-0927577-B1 | Ruthenium metathesis catalyst and method for olefin metathesis using the same | TAKASAGO PERFUMERY CO LTD (JP) | 2004-06-23 | — | — | EP | disclosed |
| US-6313365-B1 | Ruthenium metathesis catalyst and method for producing olefin reaction product by metathesis reaction using the same | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2001-11-06 | — | — | US | disclosed |
| US-6175047-B1 | A CATALYST MIXTURE INCLUDING A RUTHENIUM COMPOUND, A DIHALOGENO COMPOUND, A TERMINAL ALKYNE; AS A CATALYST FOR A CARBON-CARBON BOND FORMATION REACTION | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2001-01-16 | — | — | US | disclosed |
| EP-0927577-A1 | Ruthenium metathesis catalyst and method for producing olefin reaction product by metathesis reaction using the same | Takasago International Corporation (JP) | 1999-07-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110313169-A1 | PROCESS FOR PRODUCING PHENYL-SUBSTITUTED HETEROCYCLIC DERIVATIVE THROUGH COUPLING USING TRANSITION METAL CATALYST | XDH, PAH, HPRT1 | CYP3A4 47/4885TDP1 1180/4885GAA 460/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.